IBISBA is designed to accelerate end-to-end bioprocess development, linking best-in-class R&D facilities to provide seamless multi-technology services.
Focusing on the different R&D phases in bioprocess development, IBISBA offers services related to computer-assisted design of biocomponents, construction of enzymes and microbial strains, the fermentation, downstream processing and project knowledge asset management.
Web page: http://www.ibisba.eu
This project compiles all IBISBA-related policy notes and reports that are neither delivrables nor milestones, created for public dissemination.
The MoU is a non-binding framework for cooperation between IBISBA partners. It was finalized in 2022 and has been signed by 20 RTOs and
Deliverable 3.4 describing a roadmap to create IBISBA-ERIC.
Addressing a gap in European industrial biotechnology, IBISBA’s mission is to provide world-class cutting-edge research infrastructure services enabling the development of industrial biotechnology as a technological cornerstone of the circular bioeconomy. In this regard, IBISBA aims to contribute to the delivery of Europe’s ambition to be the first climate neutral continent in 2050. To fulfil its mission, IBISBA is building an interoperable ...
This first IBISBA policy brief provides an overview of state of play in industrial biotechnology and underlines the need for further investment in Europe.
This policy note is the second one produced by IBISBA. It briefly describes international developments in the field of industrial biotechnology and alerts on the fact that Europe risks to lose its competitive edge.